
Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Zydus Cadila receives final approval from USFDA for Droxidopa Capsules. ".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Zydus Cadila receives final approval from USFDA for Droxidopa Capsules. ".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences